HU162735B - - Google Patents

Info

Publication number
HU162735B
HU162735B HUBO1177A HUBO001177A HU162735B HU 162735 B HU162735 B HU 162735B HU BO1177 A HUBO1177 A HU BO1177A HU BO001177 A HUBO001177 A HU BO001177A HU 162735 B HU162735 B HU 162735B
Authority
HU
Hungary
Application number
HUBO1177A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU162735B publication Critical patent/HU162735B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/041,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUBO1177A 1968-03-26 1969-03-25 HU162735B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770061 DE1770061A1 (de) 1968-03-26 1968-03-26 Neue substituierte 3-Amino-4-bromsydnomimine

Publications (1)

Publication Number Publication Date
HU162735B true HU162735B (https=) 1973-04-28

Family

ID=5700383

Family Applications (1)

Application Number Title Priority Date Filing Date
HUBO1177A HU162735B (https=) 1968-03-26 1969-03-25

Country Status (18)

Country Link
AT (1) AT285619B (https=)
BE (1) BE730510A (https=)
BG (1) BG15220A3 (https=)
BR (1) BR6907417D0 (https=)
CA (1) CA945990A (https=)
CH (1) CH519511A (https=)
DE (1) DE1770061A1 (https=)
DK (1) DK130296B (https=)
ES (2) ES364979A1 (https=)
FI (1) FI54480C (https=)
FR (1) FR2004770A1 (https=)
GB (1) GB1219254A (https=)
HU (1) HU162735B (https=)
IE (1) IE32708B1 (https=)
IL (1) IL31909A (https=)
NL (1) NL6904632A (https=)
SE (1) SE374746B (https=)
YU (1) YU69369A (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
FR2004770A1 (https=) 1969-11-28
AT285619B (de) 1970-11-10
IE32708L (en) 1969-09-26
YU69369A (en) 1978-09-18
GB1219254A (en) 1971-01-13
IE32708B1 (en) 1973-10-31
IL31909A (en) 1973-01-30
BG15220A3 (bg) 1975-11-21
BE730510A (https=) 1969-09-26
IL31909A0 (en) 1969-05-28
FI54480B (fi) 1978-08-31
SE374746B (https=) 1975-03-17
ES376981A1 (es) 1972-05-01
DK130296C (https=) 1975-06-30
NL6904632A (https=) 1969-09-30
ES364979A1 (es) 1971-02-16
FI54480C (fi) 1978-12-11
DK130296B (da) 1975-02-03
CA945990A (en) 1974-04-23
DE1770061A1 (de) 1971-09-16
BR6907417D0 (pt) 1973-04-12
CH519511A (de) 1972-02-29

Similar Documents

Publication Publication Date Title
DK130296C (https=)
BE726269A (https=)
BE709435A (https=)
BE728453A (https=)
BE728381A (https=)
BE728253A (https=)
BE728464A (https=)
BE727933A (https=)
BE727750A (https=)
BE727710A (https=)
BE727595A (https=)
BE728507A (https=)
BE727507A (https=)
BE725114A (https=)
BE727268A (https=)
BE727248A (https=)
BE727221A (https=)
BE727077A (https=)
BE727043A (https=)
BE726442A (https=)
BE709320A (https=)
AU4224469A (https=)
BE725718A (https=)
BE709496A (https=)
BE723524A (https=)